Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.35 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1229892 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL3091759 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL340911 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL138043 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL1228462 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL6037442 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL630825 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL6037453 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL6037374 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT | |
| SCHEMBL6037371 | 1.00 | TSHR (0.46) | TSHRLMNAALDH1A1LPAR3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119899310-A | Acrylate polymer, ultraviolet-curable adhesive composition and polarizer | 恒美光电股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-117567943-A | Liquid encapsulation composition, photovoltaic module and encapsulation method thereof | 杭州福斯特应用材料股份有限公司 | 2024-02-20 | — | — | CN | claimed |
| EP-3340252-A1 | ELECTRODE ASSEMBLY | Solvay SA (BE) | 2018-06-27 | — | — | EP | claimed |
| EP-3340253-A1 | UV-RESISTANT ELECTRODE ASSEMBLY | Solvay SA (BE) | 2018-06-27 | — | — | EP | claimed |
| US-20260116040-A1 | LAMINATE, OPTICAL MEMBER, AND OPTICAL DEVICE | NITTO DENKO CORP (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4729294-A1 | LAMINATE, OPTICAL MEMBER, AND OPTICAL DEVICE | Nitto Denko Corporation (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4726006-A1 | PRESSURE-SENSITIVE ADHESIVE SHEET | Nitto Denko Corporation (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-4692265-A1 | THREAD-SHAPED PRESSURE-SENSITIVE ADHESIVE BODY | Nitto Denko Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4681919-A1 | LAMINATE, OPTICAL MEMBER, OPTICAL DEVICE, AND METHOD FOR PRODUCING LAMINATE | Nitto Denko Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20260013767-A1 | ADHESIVE ELECTRODE FOR BIOSIGNAL ACQUISITION AND BIOSENSOR | NITTO DENKO CORP (JP) | 2026-01-15 | — | — | US | disclosed |
| US-20250339075-A1 | BIOLOGICAL SENSOR | NITTO DENKO CORP (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-4624544-A1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITION AND PRESSURE-SENSITIVE ADHESIVE SHEET | NITTO DENKO CORPORATION (JP) | 2025-10-01 | — | — | EP | disclosed |
| US-5922519-A | DESILVERIZING PHOTOSENSITIVE SILVER HALIDE MATERIAL HAVING MAGNETIC RECORDING LAYER USING FIXING BATH CONTAINING THIOUREA COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1999-07-13 | — | — | US | disclosed |
| US-5902847-A | COMPOSITION PREPARED BY MIXING ORGANIC SOLVENT BASED COATING WITH SILICONE POLYMER HAVING ORGANOFUNCTIONAL GROUP AND HYDROLYZABLE GROUP IN ONE MOLECULE | KANSAI PAINT CO., LTD. (JP) | 1999-05-11 | — | — | US | disclosed |
| EP-0880053-A2 | Shading spacers for liquid crystal displays, process of producing such spacers, and liquid crystal display element comprising such spacers | Natoco Paint Co., Ltd. (JP) | 1998-11-25 | — | — | EP | disclosed |
| EP-0846739-A2 | Coating composition and method for application thereof | KANSAI PAINT CO., LTD. (JP) | 1998-06-10 | — | — | EP | disclosed |
| EP-0823450-A1 | COMPOSITE AND MOLDINGS PRODUCED THEREFROM | MITSUBISHI RAYON CO., LTD. (JP) | 1998-02-11 | — | — | EP | disclosed |
| EP-0773466-A1 | LIQUID CRYSTAL DISPLAY DEVICE, METHOD OF PRODUCTION OF SPACER, AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SPACER | Natoco Paint Co., Ltd. (JP) | 1997-05-14 | — | — | EP | disclosed |
| EP-0603582-B1 | Silver halide photographic material including a magnetic recording layer | FUJI PHOTO FILM CO LTD (JP) | 1997-02-05 | — | — | EP | disclosed |
| EP-0603582-A1 | Silver halide photographic material including a magnetic recording layer | FUJI PHOTO FILM CO., LTD. (JP) | 1994-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116040-A1 | LAMINATE, OPTICAL MEMBER, AND OPTICAL DEVICE | CDH1, ICAM1, ILK | TSHR 4581/4885LMNA 1171/4885ALDH1A1 2979/4885 |
| US-20260013767-A1 | ADHESIVE ELECTRODE FOR BIOSIGNAL ACQUISITION AND BIOSENSOR | ICAM1, CUTA, L1CAM | TSHR 4231/4885LMNA 2628/4885ALDH1A1 414/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.